Sustainability

How can pharma manufacturing align with green initiatives while maintaining efficiency and compliance?

Pharma's Almanac

Biomanufacturing

Enabling Digital Twins With Computational Fluid Dynamics Modeling

Sangmin Paik, Ph.D.

Samsung Biologics

AI

AI Implementation to Enhance Quality

Seongil Cho; Hyeokgeon Kwon; Kisung Shim

Samsung Biologics

Lyophilization

Enhancing Biopharmaceutical Stability Through Lyophilization

David King; Hoju Lee; Sungjin Park; Yeonju Yoon

Samsung Biologics

Innovation

How is the pharmaceutical industry integrating innovations from adjacent industries to enhance drug development and production?

Pharma's Almanac

RNA

Optimized Residual dsRNA Detection for mRNA Therapeutics

Eunseo (Ency) Lee, Ph.D; Namhyun Kim; Hwanjun Yoon, Ph.D.; Sukhwan Kim; Ahyeon Hwang

Samsung Biologics

Developability

Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform

Heonchang Lim

Samsung Biologics

Sequence Variants

Accelerating Protein Sequence Variant Analysis

Kyoungmin Lee; Yunjeong Heo; Jongbae Park

Samsung Biologics

Changing Roles

How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?

Pharma's Almanac

Global Access

How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?

Pharma's Almanac

Regulatory

Building a Path to Approval with Effective Regulatory Support

Mira Han

Samsung Biologics

Trusted Partnerships

Partnerships for Success

Ryan Lee

Samsung Biologics

Digitalization

How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?

Pharma's Almanac

Investment

What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?

Pharma's Almanac